Page last updated: 2024-10-29

indirubin-3'-monoxime and Skin Neoplasms

indirubin-3'-monoxime has been researched along with Skin Neoplasms in 1 studies

indirubin-3'-monoxime: has antiangiogenic activity
indirubin-3'-monoxime : A member of the class of biindoles that is indirubin in which the keto group at position 3' has undergone condensation with hydroxylamine to form the corresponding oxime.

Skin Neoplasms: Tumors or cancer of the SKIN.

Research Excerpts

ExcerptRelevanceReference
"Due to the increasing number of human skin cancers and the limited effectiveness of therapies, research into innovative therapeutic approaches is of enormous clinical interest."1.72Synergistic effect of plasma-activated medium and novel indirubin derivatives on human skin cancer cells by activation of the AhR pathway. ( Bergemann, C; Emmert, S; Hein, M; Lalk, M; Langer, P; Nebe, B; Rebl, H; Sawade, M; Wende, M, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Rebl, H1
Sawade, M1
Hein, M1
Bergemann, C1
Wende, M1
Lalk, M1
Langer, P1
Emmert, S1
Nebe, B1

Other Studies

1 other study available for indirubin-3'-monoxime and Skin Neoplasms

ArticleYear
Synergistic effect of plasma-activated medium and novel indirubin derivatives on human skin cancer cells by activation of the AhR pathway.
    Scientific reports, 2022, 02-15, Volume: 12, Issue:1

    Topics: Apoptosis; Basic Helix-Loop-Helix Transcription Factors; Cell Line, Tumor; Cell Proliferation; Cell

2022